Evidence map›Paper›PMID 35013907›Full record

ArticleNeurotoxicity research2022

TREM2 Ameliorates Lipopolysaccharide-Induced Oxidative Stress Response and Neuroinflammation by Promoting Sirtuin3 in BV2 Cells.

Hongqing Li, Fang Liu, Wenwen Jiang, Kexin Wang, Xuezhao Cao, Jie Zou, Yongjian Zhou, Zhe Li, Sidan Liu, Xiaotong Cui and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Sirtuin-3: A potential target for treating several types of brain injury.Frontiers in cell and developmental biology · 2023
    Review
  14. The sirtuin family in health and disease.Signal transduction and targeted therapy · 2022
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongqing LiDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Fang LiuDepartment of Neurology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Wenwen JiangDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Kexin WangDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Xuezhao CaoDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China. xuezhaocao2011@163.com.
Jie ZouDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Yongjian ZhouDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Zhe LiDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Sidan LiuDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Xiaotong CuiDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.
Xinyue ZhangDepartment of Anesthesiology, The First Hospital of China Medical University, Liaoning, Shenyang, China.

Funding

Foundation of Liaoning Province Education Administration QN2019007Key Technology Research and Development Program of Shandong SQ2018YFC200044National Natural Science Foundation of China 81300938Natural Science Foundation of Liaoning Province 20180550022
6 · The paper itself

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) plays a crucial role in modulating microglial-mediated neuroinflammation. The NAD-dependent deacetylase protein Sirtuin 3 (SIRT3) regulates mitochondrial oxidative stress response and neuroinflammation. TREM2 deficiency impairs the denovo synthesis pathway of NAD

Indexed as

Sirtuin 3HumansInflammasomesLipopolysaccharidesMembrane GlycoproteinsMicrogliaNeuroinflammatory DiseasesOxidative StressReceptors, ImmunologicInflammasomesLipopolysaccharidesMembrane GlycoproteinsReceptors, ImmunologicSirtuin 3TREM2 protein, humanNeuroinflammationNLRP3 inflammasomeOxidative stressPostoperative cognitive dysfunctionSIRT3TREM2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.